Author + information
Basra SS, Tsai P, Lakkis NM. Safety and efficacy of antiplatelet and antithrombotic therapy in acute coronary syndrome patients with chronic kidney disease. J Am Coll Cardiol 2011;58:2263–9.
In the paper above, dabigatran was classified under the subtitle “Direct factor Xa inhibitors” but should have been listed under a new subtitle of “Oral director thrombin inhibitor.”
The authors apologize for this error.
- American College of Cardiology Foundation